Thomas Hoeg-Jensen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Structure Activity Relationship

Induced Pluripotent Stem Cells

Top Venues

Journal of medicinal chemistry

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Claire Park, Yanxian Zhang, Jae Un Jung, Line Due Buron, Nai-Pin Lin, Thomas Hoeg-Jensen, Danny Hung-Chieh Chou
Antagonistic Insulin Derivative Suppresses Insulin-Induced Hypoglycemia. Journal of medicinal chemistry (2023)
Konstantinos Solomos, Victoria Tarus, Vladislav Kotek, Gaetano Invernizzi, Thomas Hoeg-Jensen
Diboronate Fluorophore for the Measurement of l-Glucose and Other Carbohydrates and Its Interaction with Albumin. ACS omega 7 (28) (2022)
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten Enggaard Stidsen, Trine Porsgaard, Christian Fledelius, Hanne Hoffman Frølund Refsgaard, Sanne Gram-Nielsen, Helle Naver, Lone Pridal, Thomas Hoeg-Jensen, Claus Bekker Jeppesen, Valentina Manfè, Svend Ludvigsen, Inger Lautrup-Larsen, Peter Madsen
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans. Journal of medicinal chemistry 64 (13) (2021)
Lasse Sander Dreyer, Jesper Nygaard, Leila Malik, Thomas Hoeg-Jensen, Rasmus Høiberg-Nielsen, Søren Roi Midtgaard
Structural Insight into the Self-Assembly of a Pharmaceutically Optimized Insulin Analogue Obtained by Small-Angle X-ray Scattering. Molecular pharmaceutics 17 (8) (2020)
Thomas B Kjeldsen, František Hubálek, Tina M Tagmose, Lone Pridal, Hanne Hoffman Frølund Refsgaard, Trine Porsgaard, Sanne Gram-Nielsen, Lars Hovgaard, Henrik Valore, Martin Münzel, Claudia U Hjørringgaard, Claus Bekker Jeppesen, Valentina Manfè, Thomas Hoeg-Jensen, Svend Ludvigsen, Peter Kresten Nielsen, Inger Lautrup-Larsen, Carsten Enggaard Stidsen, Erik M Wulff, Patrick W Garibay, János T Kodra, Erica Nishimura, Peter Madsen
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320. Journal of medicinal chemistry 64 (1) (2020)